| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc. (ACAD) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. ACAD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 66.1K | $1.88M | - | |
| 10% | 32.0K | $910.6K | - | |
| VP | 19.0K | $540.4K | -16,558 | |
| CEO | 14.8K | $421.1K | - | |
| Other | 13.1K | $372.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | Teehan Brendan62 | EVP, COO, Head Of Commercial | Sell | 9,534 | $15.28 | $145,679.52 | -15.4% | +8.1% | +58.4% | |
| Aug 19, 2024 | Davis Stephen68 | CEO | Sell | 31,747 | $15.28 | $485,094.16 | -14.5% | +8.1% | +58.4% | |
| Aug 19, 2024 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sell | 9,733 | $15.28 | $148,720.24 | -18.2% | +8.1% | +58.4% | |
| Jun 10, 2024 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sale+OE | 975 | $14.79 | $14,420.25 | -2.7% | +6.0% | +49.2% | |
| May 2, 2024 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sale+OE | 3,503 | $16.94 | $59,340.82 | -9.9% | +11.4% | -12.7% | |
| May 2, 2024 | Teehan Brendan62 | EVP, COO, Head Of Commercial | Sale+OE | 3,477 | $16.94 | $58,900.38 | -7.6% | +11.4% | -12.7% | |
| May 2, 2024 | Kihara James62 | Principal Accounting Officer | Sale+OE | 1,326 | $16.94 | $22,462.44 | -8.4% | +11.4% | -12.7% | |
| May 2, 2024 | Davis Stephen68 | CEO | Sale+OE | 11,427 | $16.94 | $193,573.38 | -6.9% | +11.4% | -12.7% | |
| Apr 8, 2024 | Davis Stephen68 | CEO | Sale+OE | 26,574 | $17.87 | $474,877.38 | -8.0% | -8.3% | -20.8% | |
| Apr 8, 2024 | Teehan Brendan62 | EVP, COO, Head Of Commercial | Sale+OE | 2,568 | $17.87 | $45,890.16 | -6.2% | -8.3% | -20.8% |